Molecular morphology of hodgkin lymphoma

Applied Immunohistochemistry and Molecular Morphology

Volumn 9, Issue 3, 2001, Pages 187-202

  Taylor, C R ^a   Riley, C R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Diagnosis; History; Hodgkin disease; Hodgkin lymphoma; Immunohistochemistry; Molecular biology; Reed Sternberg cells

Indexed keywords

CLINICAL FEATURE; DISEASE CLASSIFICATION; HISTOCHEMISTRY; HODGKIN DISEASE; HUMAN; IMMUNOLOGY; INFECTION; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; REED STERNBERG CELL; REVIEW; ULTRASTRUCTURE;

ANIMALS; DNA, NEOPLASM; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MICROSCOPY, ELECTRON; REED-STERNBERG CELLS; RNA, NEOPLASM;

EID: 0034850246     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200109000-00001     Document Type: Review

References (133)

1. De Viscerum strutura
2. On some morbid experiences of the absorbant glands and spleen
3. Thomas Hodgkin (1798-1866): Morbid anatomist and social activist
4. Elements of general and pathological anatomy
5. Thomas Hodgkin and Hodgkin disease - Two paradigms appropriate to medicine today
6. Cases of lardaceous disease and some allied affections, with remarks
7. Cases of enlargement of the lymphatic glands and spleen, (or Hodgkin disease), with remarks
8. Histology of lymphadenoma
9. Uber eine eigenartige unter dem bilde der pseudoleukamie verlaufende tuberculose des lymphatischen apparatus
10. On the pathological changes in Hodgkin disease, with especial reference to its relation to tuberculosis
11. Hodgkin disease
12. Rose research studies in the aetiology of lymphadenoma
13. Reappraisal of the relationship between immunoglobulin heavy chain gene rearrangement and Epstein-Barr virus infection in Reed-Sternberg cells of Hodgkin disease
14. A history of the Reed-Sternberg Cell
15. Hodgkin disease: Origin of an eponym - And one that got away
16. Maude Abbott lecture. Hematopathology: A crescendo of scholarly activity
17. Classification nomenclature of the lymphoadenopathies
18. The lymphomas, lymphocytic tissue
19. The cellular biology of the Reed-Sternberg cell
20. Histochemistry of Hodgkin disease
21. The reactivity of Reed-Sternberg cells with monoclonal antisera at thin section and ultrastructural levels
22. Immunoelectron microscopic study of Hodgkin disease
23. Ultrastructural localization of Leu M1 in Reed-Sternberg cells and normal myeloid cells
24. Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin disease: Evidence for a B-cell origin of Sternberg-Reed cells
25. Lymphocytotoxins in Hodgkin disease
26. Hodgkin disease and Epstein-Barr Virus; altered antibody pattern before diagnosis
27. The many faces of Hodgkin disease around the world: What have we learned from its pathology?
28. High incidence of Epstein-Barr virus genomes in Hodgkin disease
29. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin disease and identical to those observed in nasopharyngeal carcinoma
30. Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBVpositive Hodgkin disease
31. Hodgkin disease: Cases with features of a community outbreak
32. An overview of the Third International Symposium on Hodgkin lymphoma
33. Single-cell analysis of Hodgkin and Reed-Sternberg cells: Molecular and heterogeneity of gene expression and P53 mutations
34. Possible origin of the Reed-Sternberg cell from an interdigitating reticulum cell
35. The nature of Reed-Sternberg cells and other malignant reticulum cells
36. Immunohistochemical demonstration of IgG in Reed-Sternberg cells and other cells in Hodgkin disease
37. Fixation for the 1990s: A review of needs and accomplishments
38. Antigen unmasking on formalin-fixed paraffin-embedded tissue sections
39. Effects of antigen retrieval by microwave heating in formalin-fixed tissue sections on a broad panel of antibodies
40. The influence of protease digestion and duration of fixation on the immunostaining of keratins. A comparison of formalin and ethanol fixation
41. The effects of progressive formaldehyde fixation on the preservation of tissue antigens
42. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immuno-histochemical staining based on microwave oven heating of tissue sections
43. Optimizing immunohistochemistry in diagnostic tumor pathology with antigen retrieval
44. Brief, high-temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues
45. Optimizing immunohistochemistry: Antigen retrieval and signal amplification
46. Isolation of Reed-Sternberg cells from lymph nodes of Hodgkin disease patients
47. An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin disease
48. Epstein-Barr virus and CD30+ malignant lymphomas
49. Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material
50. Sternberg-Reed giant cells of Hodgkin disease: Cultivation in vitro, heterotransplantations, and characterizations as neoplastic macrophages
51. Two neoplastic cell lines with unique features derived from Hodgkin disease
52. Immunohistological observations of the development of reticulum cell sarcoma in the mouse
53. Growth of Hodgkin's cell lines in severely combined immunodeficient mice
54. Lymphoproliferation and heterotransplantation in nude mice: Tumor cells in Hodgkin disease
55. Disseminated growth of Hodgkin's derived cell lines L540 and L540cy in immune-deficient SCID mice
56. Hodgkin lymphoma-derived tissue serially transplanted into severed combined immunodefi-cient mice
57. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin disease and a subset of normal lymphoid cells
58. BLA.36: A glycoprotein specifically expressed on the surface of Hodgkin's and B cells
59. Growth factors in Hodgkin disease
60. Potentiation of fibroblast growth by nodular sclerosing Hodgkin disease cell cultures
61. Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin disease cases
62. Structural and biological features of the TNF receptor and TNF ligand superfamilies: Interactive signals in the pathobiology of Hodgkin disease
63. Immunology of Hodgkin disease
64. Relationship between eosinophils density and cell activation markers in lymph nodes of patient's with Hodgkin disease
65. Activation of Hodgkin's cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-κB transcription factor
66. Hodgkin disease: A tumor with disturbed immunological pathways
67. Reed-Sternberg cell: Survival in a hostile sea
68. Immune escape mechanisms in Hodgkin disease
69. Hodgkin disease: A disorder of dysregulated cellular cross-talk
70. Absence of HLA Class I expression by Reed-Sternberg cells
71. Generations of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic 2)
72. Nonrandom chromosome abnormalities in lymphoma
73. Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin disease
74. Unique display of a pathologic karyotype in Hodgkin disease by Reed-Sternberg cells
75. Cytogenetic features of Hodgkin disease suggest possible origin form a lymphocyte
76. Chromosomal abnormalities in Hodgkin disease
77. Chromosomal abnormalities in Hodgkin disease
78. Cytogenetic studies in untreated Hodgkin disease
79. Numerical chromosomal aberrations are present within the CD30+ Hodgkin Reed-Sternberg cells in 100% of analyzed cases of Hodgkin disease
80. Cytogenetics and molecular cytogenetics in Hodgkin disease
81. Comparative genomic hybridization (CGH) of single Reed-Sternberg cells
82. In cell amplification
83. Detection of specific sequences among DNA fragments separated by gel electrophoresis
84. Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction
85. Detection of immunoglobulin gene rearrangement of B cell nonHodgkin lymphoma and leukemias in fresh unfixed formalin-fixed, paraffin-embedded tissue by polymerase chain reaction
86. Rearranged antigen receptor genes in Hodgkin disease
87. Mutations in the IkBa gene in Hodgkin disease suggest a tumour suppressor role for ikappa-balpha
88. Expression of c-myc and c-ras oncogenes in the neoplastic and non-neoplastic cells of Hodgkin disease
89. Role of the Bcl-2 oncogene in Hodgkin disease
90. Bcl-2 rearrangement in Hodgkin disease and reactive lymph nodes
91. An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin disease
92. Abnormal expression of the p53 binding protein in Hodgkin disease
93. p53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin disease
94. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development
95. Single cell analysis of H/RS cells
96. Single cell PCR for the analysis of Hodgkin's disese: Four years later
97. Hodgkin and Reed-Sternberg cells isolated from lymph nodes are clonal populations of highly differentiated B cells
98. Molecular single cell studies of normal and transformed lymphocytes
99. Representative in vitro cDNA amplification from individual hematopoietic cells and colonies
100. Report on the workshop biology of the Third International Symposium on Hodgkin lymphoma in Cologne 1995
101. Reed-Sternberg cell genome expression supports a B-cell lineage
102. Pathology and 'molecular histology' of Hodgkin disease and the border to non-Hodgkin lymphomas
103. Demonstration of monoclonal EBV genomes in Hodgkin disease and ki-1 anaplastic large cell lymphoma by combined southern blot and in-situ hybridization
104. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin disease, and reactive lymphoid lesions
105. ALK gene products in anaplastic large cell lymphomas and Hodgkin disease
106. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin lymphomas of T-cell phenotype, and in Hodgkin disease
107. Absence of the t(2;5) in Hodgkin disease
108. Translocation t(2;5) is not a primary event in Hodgkin disease
109. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): Immunohistologic detection of EBNA1 in the malignant cells of Hodgkin disease
110. The origin of Hodgkin and Reed Sternberg cells in Hodgkin disease
111. Workshop report on Hodgkin disease and related diseases ('grey zone' lymphoma)
112. Hodgkin disease biology: Recent advances
113. Expression of BCL-6 and syndecin-1 identifies distinct histologic subtype of Hodgkin disease
114. Differential diagnosis between classic Hodgkin lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry
115. Unresolved issues concerning Hodgkin disease and its relationship to non-Hodgkin lymphoma
116. The interface of Hodgkin disease and anaplastic large cell lymphoma
117. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study group
118. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report
119. Leu Ml and peanut agglutinin stain the neoplastic cells of Hodgkin disease
120. Hodgkin's cells express a novel pattern of adhesion molecules
121. The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin disease using fixed frozen tissue
122. Functional characterization of a potential receptor for grown factor of human B and Reed-Sternberg cells
123. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin disease
124. The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma
125. Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin disease of nodular subtype contain J-Chain
126. Aberrant cytoplasmic expression of proliferating cell nuclear antigen in Hodgkin disease
127. Proliferating cell nuclear antigen (PCNA) nucleolar organiser regions in Hodgkin disease: Correlation with morphology
128. Monoclonal antibodies in the diagnosis of Hodgkin disease